A project from the American Society of Retina Specialists
Sign in to view content
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
- Video
- Published 2020
Related
Category: AMD-Neovascular